Cosentino, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 2.259
EU - Europa 2.199
AS - Asia 1.448
SA - Sud America 251
AF - Africa 33
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 4
Totale 6.202
Nazione #
US - Stati Uniti d'America 2.221
DE - Germania 1.122
SG - Singapore 646
CN - Cina 395
SE - Svezia 277
UA - Ucraina 224
BR - Brasile 199
FR - Francia 137
VN - Vietnam 104
GB - Regno Unito 100
IT - Italia 98
IE - Irlanda 61
IN - India 58
FI - Finlandia 53
ID - Indonesia 47
RU - Federazione Russa 38
JP - Giappone 31
TR - Turchia 31
AR - Argentina 22
AT - Austria 21
BD - Bangladesh 21
CA - Canada 18
IQ - Iraq 18
HK - Hong Kong 16
PK - Pakistan 11
PL - Polonia 10
ZA - Sudafrica 10
IR - Iran 9
MX - Messico 9
BE - Belgio 8
ES - Italia 8
NL - Olanda 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
EC - Ecuador 7
EU - Europa 6
MY - Malesia 6
VE - Venezuela 6
CL - Cile 5
CO - Colombia 5
LT - Lituania 5
DZ - Algeria 4
KE - Kenya 4
PE - Perù 4
PH - Filippine 4
AL - Albania 3
BY - Bielorussia 3
DK - Danimarca 3
EG - Egitto 3
HN - Honduras 3
JO - Giordania 3
MA - Marocco 3
NO - Norvegia 3
PS - Palestinian Territory 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
BB - Barbados 2
CY - Cipro 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
IL - Israele 2
KR - Corea 2
KW - Kuwait 2
LB - Libano 2
OM - Oman 2
SN - Senegal 2
TJ - Tagikistan 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KI - Kiribati 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
NP - Nepal 1
PT - Portogallo 1
PW - Palau 1
PY - Paraguay 1
Totale 6.198
Città #
Chandler 400
Singapore 354
Ashburn 218
San Jose 204
Jacksonville 117
San Mateo 112
Nanjing 70
Nürnberg 68
Beijing 66
Munich 66
Dublin 60
New York 57
Los Angeles 54
Wilmington 46
Jakarta 43
Boston 37
Bremen 36
Lawrence 36
Ann Arbor 35
Lauterbourg 35
Dearborn 34
Ho Chi Minh City 34
Nanchang 34
Cattolica 30
Marseille 30
Frankfurt am Main 26
Moscow 26
Woodbridge 25
Detroit 24
Fairfield 24
Tokyo 24
Hefei 23
Dallas 22
Hanoi 22
Seattle 22
Izmir 21
Milan 21
Buffalo 20
Vienna 19
Redwood City 18
Leawood 17
Hong Kong 15
Kunming 15
São Paulo 15
University Park 15
Houston 14
Mountain View 13
Tianjin 13
Zhengzhou 13
Jiaxing 12
Norwalk 11
Fremont 10
Lancaster 10
Paris 10
The Dalles 10
Augusta 9
Changsha 9
Shenyang 9
Brussels 8
Jinan 8
Rio de Janeiro 8
San Francisco 8
Santa Clara 8
Boardman 7
Campinas 7
Da Nang 7
Guangzhou 7
Hebei 7
Philadelphia 7
Renton 7
Shanghai 7
Tashkent 7
Turku 7
Falls Church 6
London 6
Orem 6
Princeton 6
Pune 6
Washington 6
Baghdad 5
Belo Horizonte 5
Chennai 5
Dhaka 5
Erbil 5
Helsinki 5
Kent 5
Lahore 5
Montreal 5
Stockholm 5
Amsterdam 4
Brasília 4
Brooklyn 4
Cambridge 4
Changchun 4
Chicago 4
Costa Mesa 4
Guarulhos 4
Kraków 4
Kuala Lumpur 4
Nairobi 4
Totale 3.073
Nome #
CD4+CD28null T lymphocytes are expanded in young women with polycystic ovary syndrome 240
Baseline C-Reactive Protein Serum Levels and In-Stent Restenosis Pattern After m-TOR Inhibitors Drug-Eluting Stent Implantation 240
Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents 211
Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role 198
Angiographic patterns of myocardial reperfusion after primary angioplasty and ventricular remodeling 194
Eosinophil cationic protein and clinical outcome after bare metal stent implantation 184
Eosinophili cationic protein: a new biomarker of coronary atherosclerosis 184
Impact of gender on clinical outcomes after mTOR-inhibitor drug-eluting stent implantation in patients with first manifestation of ischaemic heart disease 178
Drug eluting stent and coronary chronic total occlusions 177
Case-control registry of excimer laser coronary angioplasty versus distal protection devices in patients with acute coronary syndromes due to saphenous vein graft disease 176
CD4(+)CD28(null) T lymphocyte frequency, a new marker of cardiovascular risk: relationship with polycystic ovary syndrome phenotypes 175
Eosinophil cationic protein and clinical outcome after bare metal stent implantation 170
Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role 167
Parvovirus B19 at the culprit coronary stenosis predicts outcome after stenting 160
Predictors of thromboxane levels in patients with non-ST-elevation acute coronary syndromes on chronic aspirin therapy 158
No-reflow: incidence and detection in the cath-lab 158
Coronary atherosclerotic burden in patients with infection by CagA-positive strains of Helicobacter pylori 156
Laser for complex coronary lesions: impact of excimer lasers and technical advancements 150
Serum levels of γ-glutamyltransferase and progression of coronary atherosclerosis 150
A meta-analysis of first-generation drug-eluting vs bare-metal stents for coronary chronic total occlusion: effect of length of follow-up on clinical outcome 146
No-reflow reversibility: a study based on serial assessment of multiple biomarkers 145
Impact of microvascular obstruction and infarct size on left ventricular remodeling in reperfused myocardial infarction: a contrast-enhanced cardiac magnetic resonance imaging study 143
Impact of accuracy of fractional flow reserve to reduction of microvascular resistance after intracoronary adenosine in patients with angina pectoris or non-ST-segment elevation myocardial infarction 139
Endogenous serum erythropoietin and no-reflow in patients with ST-elevation myocardial infarction 137
New strategies for the management of no-reflow after primary percutaneous coronary intervention 134
Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction) 134
Severity of coronary atherosclerosis in patients with a first acute coronary event: a diabetes paradox 131
Colon-like right coronary artery 127
Predictors of myocardial microvascular obstruction in patients treated by primary percutaneous coronary intervention and a short ischemic time 125
Cytotoxin-associated gene antigen-positive strains of Helicobacter pylori and recurring acute coronary syndromes 124
Data on the lipoprotein (a), coronary atherosclerotic burden and vulnerable plaque phenotype in angiographic obstructive coronary artery disease 121
Protective effect of pre-infarction angina on microvascular obstruction after primary percutaneous coronary intervention is blunted in humans by cardiovascular risk factors 120
Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease 119
Impact of electronegative low-density lipoprotein on angiographic coronary atherosclerotic burden 118
A complex case of angulated and bifurcated lesion facilitated by excimer laser coronary angioplasty 117
Morphological-biohumoral correlations in acute coronary syndromes: Pathogenetic implications 116
Cytotoxin-associated gene antigen-positive strains of Helicobacter pylori and recurring acute coronary syndromes 111
Microvascular obstruction after primary percutaneous coronary intervention: pathogenesis, diagnosis and prognostic significance 105
Letter by Niccoli et al regarding article, "intracoronary versus intravenous administration of abciximab in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of st-segment elevation myocardial infarction (CICERO) trial" 101
Patients with microvascular obstruction after primary percutaneous coronary intervention show a gp91phox (NOX2) mediated persistent oxidative stress after reperfusion 99
Eosinophils: a new player in coronary atherosclerotic disease 87
Predictors of thromboxane levels in patients with non-ST-elevation acute coronary syndromes on chronic aspirin therapy 82
Excimer laser coronary angioplasty with manual thrombus aspiration for a case of very late stent thrombosis of sirolimus-eluting stent 76
Totale 6.283
Categoria #
all - tutte 23.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.374


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202182 0 0 0 0 0 0 0 0 0 10 63 9
2021/2022464 22 47 14 18 27 18 20 90 20 31 64 93
2022/2023987 133 164 100 167 52 115 42 72 111 5 19 7
2023/2024307 15 96 10 9 10 59 18 5 5 7 37 36
2024/2025667 19 41 67 23 84 9 10 33 91 38 143 109
2025/20261.613 298 39 86 138 317 107 292 83 139 114 0 0
Totale 6.283